156 related articles for article (PubMed ID: 32102131)
21. Plasma CC-chemokine ligand 28 level is correlated with hematopoietic stem cells in human cord blood.
Yoon JH; Oh S; Shin S; Roh EY; Lee HR; Seo SH; Park H; Song EY
Transfusion; 2015 May; 55(5):1008-12. PubMed ID: 25412854
[TBL] [Abstract][Full Text] [Related]
22. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
[TBL] [Abstract][Full Text] [Related]
23. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.
Serada S; Fujimoto M; Terabe F; Iijima H; Shinzaki S; Matsuzaki S; Ohkawara T; Nezu R; Nakajima S; Kobayashi T; Plevy SE; Takehara T; Naka T
Inflamm Bowel Dis; 2012 Nov; 18(11):2169-79. PubMed ID: 22374925
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha.
Wu F; Zikusoka M; Trindade A; Dassopoulos T; Harris ML; Bayless TM; Brant SR; Chakravarti S; Kwon JH
Gastroenterology; 2008 Nov; 135(5):1624-1635.e24. PubMed ID: 18835392
[TBL] [Abstract][Full Text] [Related]
25. Regulated production of the chemokine CCL28 in human colon epithelium.
Ogawa H; Iimura M; Eckmann L; Kagnoff MF
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1062-9. PubMed ID: 15246961
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.
Wine E; Mack DR; Hyams J; Otley AR; Markowitz J; Crandall WV; Leleiko N; Muise AM; Griffiths AM; Turner D
J Crohns Colitis; 2013 Dec; 7(11):916-22. PubMed ID: 23339932
[TBL] [Abstract][Full Text] [Related]
27. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.
Yu LZ; Wang HY; Yang SP; Yuan ZP; Xu FY; Sun C; Shi RH
World J Gastroenterol; 2013 May; 19(17):2638-49. PubMed ID: 23674871
[TBL] [Abstract][Full Text] [Related]
28. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
[TBL] [Abstract][Full Text] [Related]
29. Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis.
Kanmura S; Uto H; Numata M; Hashimoto S; Moriuchi A; Fujita H; Oketani M; Ido A; Kodama M; Ohi H; Tsubouchi H
Inflamm Bowel Dis; 2009 Jun; 15(6):909-17. PubMed ID: 19107772
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical activity of Prohibitin-2 and Stomatin-Like Protein-2 in patients with ulcerative colitis.
Küçük İ; Tanoğlu A; Öncü K; Yılmaz İ; Kara M; Beyazıt Y; Akyol T; Kaplan M; Özarı HO; Yazgan Y
Turk J Gastroenterol; 2016 May; 27(3):233-8. PubMed ID: 27124283
[TBL] [Abstract][Full Text] [Related]
31. Comparison of CCL28, interleukin-8, interleukin-1β and tumor necrosis factor-alpha in subjects with gingivitis, chronic periodontitis and generalized aggressive periodontitis.
Ertugrul AS; Sahin H; Dikilitas A; Alpaslan N; Bozoglan A
J Periodontal Res; 2013 Feb; 48(1):44-51. PubMed ID: 22812409
[TBL] [Abstract][Full Text] [Related]
32. [Expression of calprotectin in colon mucosa and fecal of patients with ulcerative colitis].
Liu WB; Lü YM; Jin Z; Yang XL
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):179-82. PubMed ID: 15841150
[TBL] [Abstract][Full Text] [Related]
33. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D deficiency associated with Crohn's disease and ulcerative colitis: a meta-analysis of 55 observational studies.
Li XX; Liu Y; Luo J; Huang ZD; Zhang C; Fu Y
J Transl Med; 2019 Sep; 17(1):323. PubMed ID: 31547829
[TBL] [Abstract][Full Text] [Related]
35. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.
Zhang P; Liu X; Guo A; Xiong J; Fu Y; Zou K
Dig Dis Sci; 2016 Sep; 61(9):2608-18. PubMed ID: 27056038
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha serum level in assessment of disease activity in inflammatory bowel diseases.
Avdagić N; Babić N; Šeremet M; Delić-Šarac M; Drače Z; Denjalić A; Nakaš-Ićindić E
Med Glas (Zenica); 2013 Aug; 10(2):211-6. PubMed ID: 23892833
[TBL] [Abstract][Full Text] [Related]
37. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of fecal myeloperoxidase as a biomarker of disease activity and severity in ulcerative colitis.
Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Hussain S; Singh K
Dig Dis Sci; 2012 May; 57(5):1336-40. PubMed ID: 22350781
[TBL] [Abstract][Full Text] [Related]
39. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
[TBL] [Abstract][Full Text] [Related]
40. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
Wang ZL; Wang YD; Wang K; Li JA; Li L
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
